We use cookies to understand how you use our site and to improve your experience. Please refer to our Terms and Conditions and Privacy Policy for more information about the cookies we use and how we protect your privacy.
Introducing Viracor TRAC™ Kidney
NOW AVAILABLE TO ORDER!
A noninvasive donor-derived cell-free DNA assay for
evaluating rejection in kidney transplant patients.
Join us for "GVHD Diagnostics: Using the MAGIC Algorithm Probability (MAP) to guide Acute GVHD Treatment"
Presented by Drs. James Ferrara and Ryotaro Nakamura
2020 TCT Meetings in Orlando, Saturday, February 22th, 1:30 - 2:30 PM
Rule Out Silent Kidney Rejection
TruGraf® is the first noninvasive biomarker-guided
blood monitoring assay to rule out subclinical rejection
in patients with stable renal function.
We've Got Respiratory Season Covered
Viracor can help with a wide range of comprehensive respiratory panels
with multiple specimen types, and additional testing to
ensure you meet the volume of the season head on.
TruGraf® Rules Out Silent Kidney Rejection.
A Game-Changing Alternative to Surveillance Biopsies
Now covered by Medicare, TruGraf® is the first biomarker-guided blood monitoring assay to rule out subclinical rejection for patients with stable renal function.
Connect with us